wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38024991-CFC91358-E82A-466F-9666-BC8C02261CF6
Q38024991-CFC91358-E82A-466F-9666-BC8C02261CF6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38024991-CFC91358-E82A-466F-9666-BC8C02261CF6
Optimising the delivery of tubulin targeting agents through antibody conjugation.
P2860
Q38024991-CFC91358-E82A-466F-9666-BC8C02261CF6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38024991-CFC91358-E82A-466F-9666-BC8C02261CF6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
157a1cd49b9a04620f655c33e53a59bc0b1ef921
P2860
A phase I dose escalation study with anti-CD44v6 bivatuzumab mertansine in patients with incurable squamous cell carcinoma of the head and neck or esophagus